ABC | Volume 114, Nº5, May 2020

Arq Bras Cardiol. 2020; 114(5):943-987 Guidelines Brazilian Cardiovascular Rehabilitation Guideline – 2020 313. Pierard LA, Lancellotti P. Stress testing in valve disease. Heart. 2007;93(6):766-72. 314. Bissessor N, Stewart R, Zeng I, Ellyet K, Kolbe J, Kerr A. Comparing Cardiopulmonary Exercise Testingwith Standard Exercise Treadmill Testing in Chronic Mixed Heart Valve Disease. Heart, Lung and Circulation. 2007;16(Suppl 2):S57-S8. 315. LeclercK.Cardiopulmonaryexercisetesting:Acontemporaryandversatile clinical tool. Cleve Clin J Med. 2017;84(2):161-8. 316. Guazzi M, Bandera F, Ozemek C, Systrom D, Arena R. Cardiopulmonary ExerciseTesting:WhatIs itsValue?JAmCollCardiol.2017;70(13):1618-36. 317. Travensolo C, Polito M. Testes de Degrau para Avaliação da Capacidade de Exercício emPacientes comDoenças Cardíacas: Revisão da Literatura. Rev Bras Cardiol. 2014;27(6):445-53. 318. de Carvalho EEV, CostaDC, Crescêncio JC, De Santi GL, Papa V, F. M, et al. Insuficiência Cardíaca : Comparação Entre o Teste de Caminhada de Seis Minutos e o Teste Cardiopulmonar. Arq Bras Cardiol. 2011;97(1):59-64. 319. Pulz C, Diniz RV, Alves AN, Tebexreni AS, Carvalho AC, de Paola AA, et al. Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol. 2008;24(2):131-5. 320. OliveiraMF, Zanussi G, Sprovieri B, LoboDM, Mastrocolla LE, Umeda, II, et al. Alternatives to Aerobic Exercise Prescription in Patients with Chronic Heart Failure. Arq Bras Cardiol. 2016;106(2):97-104. 321. Meneghelo RS, Araújo CGS, Stein R, Mastrocolla LE, Albuquerque PF, Serra SM. III Diretrizes da Sociedade Brasileira de Cardiologia sobre Teste Ergométrico. Arq Bras Cardiol. 2010;95(5 Suppl 1):1-26. 322. Picano E, Pibarot P, Lancellotti P, Monin JL, BonowRO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54(24):2251-60. 323. Lancellotti P, Dulgheru R, Go YY, Sugimoto T, Marchetta S, Oury C, et al. Stress echocardiography in patients with native valvular heart disease. Heart. 2018;104(10):807-13. 324. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43. 325. Pascual I, Munoz-Garcia AJ, Lopez-Otero D, Avanzas P, Jimenez-Navarro MF, Cid-Alvarez B, et al. Transcatheter aortic valve implantation in very elderly patients: immediate results andmedium term follow-up. J Geriatr Cardiol. 2015;12(4):340-5. 326. Kortlandt F, Velu J, Schurer R, Hendriks T, Van den Branden B, Bouma B, et al. Survival After MitraClip Treatment Compared to Surgical and Conservative Treatment for High-Surgical-Risk Patients With Mitral Regurgitation. Circ Cardiovasc Interv. 2018;11(6):e005985. 327. Vigorito C, Abreu A, Ambrosetti M, Belardinelli R, Corra U, Cupples M, et al. Frailty and cardiac rehabilitation: A call to action from the EAPCCardiac Rehabilitation Section. Eur J Prev Cardiol. 2017;24(6):577-90. 328. Voller H, Salzwedel A, Nitardy A, Buhlert H, Treszl A, Wegscheider K. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol. 2015;22(5):568-74. 329. OsnabruggeRL,ArnoldSV,ReynoldsMR,MagnusonEA,WangK,Gaudiani VA, et al. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValveU.S. trial. JACC Cardiovasc Interv. 2015;8(2):315-23. 330. Okoh AK, Chauhan D, Kang N, Haik N, Merlo A, Cohen M, et al. The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis. Catheter Cardiovasc Interv. 2017;90(6):1000-6. 331. RibeiroGS,MeloRD,DereszLF,DalLagoP,PontesMR,KarstenM.Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta- analysis. Eur J Prev Cardiol. 2017;24(7):688-97. 332. Mijnarends DM, Schols JM, Meijers JM, Tan FE, Verlaan S, Luiking YC, et al. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies. J Am Med Dir Assoc. 2015;16(4):301-8. 333. Bonow RO, Nishimura RA, Thompson PD, Udelson JE, American Heart Association E, Arrhythmias Committee of Council on Clinical Cardiology CoCDiYCoC, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e292-7. 334. Gati S, Malhotra A, Sharma S. Exercise recommendations in patients with valvular heart disease. Heart. 2019;105(2):106-10. 335. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung. 2004;33(3):176-82. 336. Thomas SA, Friedmann E, Kelley FJ. Living with an implantable cardioverter-defibrillator: a review of the current literature related to psychosocial factors. AACN Clin Issues. 2001;12(1):156-63. 337. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members. J Cardiovasc Electrophysiol. 2006;17(1):11-5. 338. Bajaj RR, Biswas A, Oh P, Alter DA. Safety of implantable cardioverter defibrillators in exercise therapy and cardiac rehabilitation: a systematic review and meta-analysis. Can J Cardiol. 2015;31(10):S264-S5. 339. Jung MH, Gustafsson F. Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant. 2015;34(4):489-96. 340. Isaksen K, Morken IM, Munk PS, Larsen AI. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation. Eur J Prev Cardiol. 2012;19(4):804-12. 341. Pandey A, Parashar A, Moore C, Ngo C, Salahuddin U, Bhargava M, et al. Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis. JACC Clin Electrophysiol. 2017;3(2):117-26. 342. Alswyan AH, Liberato ACS, Dougherty CM. A Systematic Review of Exercise Training in Patients With Cardiac Implantable Devices. J Cardiopulm Rehabil Prev. 2018;38(2):70-84. 343. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter- defibrillators: results of a prospective, multinational registry. Circulation. 2013;127(20):2021-30. 344. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of Sports for Athletes With Implantable Cardioverter- Defibrillators: Long-Term Results of a Prospective Multinational Registry. Circulation. 2017;135(23):2310-2. 345. Davids JS, McPherson CA, Earley C, Batsford WP, Lampert R. Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey. Arch Phys Med Rehabil. 2005;86(10):1924-8. 346. Pathak RK, Elliott A, MiddeldorpME, MeredithM, Mehta AB, Mahajan R, et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. J Am Coll Cardiol. 2015;66(9):985-96. 347. Billman GE. Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention. J Appl Physiol (1985). 2002;92(2):446-54. 984